106 related articles for article (PubMed ID: 3065667)
1. [Prospective evaluation of the effectiveness of high doses of methylprednisolone in multiple sclerosis].
Wajgt A; Szczechowski L; Marczewska E; Grechuta M; Strzyzewska L; Gadomska B; Szyrocka-Szwed K
Neurol Neurochir Pol; 1988; 22(3):188-94. PubMed ID: 3065667
[TBL] [Abstract][Full Text] [Related]
2. [Prospective assessment of combined treatment with high doses of intravenous methylprednisolone and long term administration of Isoprinosine in multiple sclerosis patients].
Maciejek Z; Niezgodzińska-Maciejek A
Neurol Neurochir Pol; 1993; 27(3):321-9. PubMed ID: 7694166
[TBL] [Abstract][Full Text] [Related]
3. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
4. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
[No Abstract] [Full Text] [Related]
5. [Long-term steroid therapy in multiple sclerosis].
Domzał T; Zalewska B
Neurol Neurochir Pol; 1992; 26(5):621-5. PubMed ID: 1291899
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
[TBL] [Abstract][Full Text] [Related]
7. [Results of one-year treatment of multiple sclerosis with azathioprine compared with the therapy using small doses of Encorton].
Wender M; Tokarz-Kupczyk E; Mularek O; Sniatała-Kamasa M
Neurol Neurochir Pol; 1991; 25(3):307-13. PubMed ID: 1961376
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the results of treating progressive multiple sclerosis with cyclophosphamide].
Wajgt A; Szyrocka-Szwed K; Gadomska B; Szczechowski L
Neurol Neurochir Pol; 1988; 22(6):518-23. PubMed ID: 3077433
[TBL] [Abstract][Full Text] [Related]
9. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
Jedlicka P; Kupka J; Kocinová F
Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
[No Abstract] [Full Text] [Related]
10. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
11. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
Alam SM; Kyriakides T; Lawden M; Newman PK
J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance imaging after a one-month interval of lesions of multiple sclerosis in 2 populations, one during an acute attack treated with methylprednisolone, the other stable with no treatment].
Rumbach L; Dietemann JL; Tranchant C; Bodiguel E; Warter JM; Collard M
Rev Neurol (Paris); 1990; 146(6-7):430-3. PubMed ID: 2399406
[TBL] [Abstract][Full Text] [Related]
14. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
Uttner I; Müller S; Zinser C; Maier M; Süssmuth S; Claus A; Ostermann B; Elitok E; Ecker D; Brettschneider J; Gold R; Tumani H
Neurology; 2005 Jun; 64(11):1971-3. PubMed ID: 15955958
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
[TBL] [Abstract][Full Text] [Related]
16. [Comparative treatment of acute optic neuritis with "boluses" of intravenous methylprednisolone or oral prednisone].
Alejandro PM; Castañón González JA; Miranda Ruiz R; Edgar Echeverria R; Adriana Montãno M
Gac Med Mex; 1994; 130(4):227-30. PubMed ID: 8964329
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
18. [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk].
Dtsch Med Wochenschr; 1994 Jun; 119(24):897. PubMed ID: 8005072
[No Abstract] [Full Text] [Related]
19. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
Milligan NM; Newcombe R; Compston DA
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):511-6. PubMed ID: 3295122
[TBL] [Abstract][Full Text] [Related]
20. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
Sigwald J; Mazalton A; Raymondeaud C; Piot C; Jacquillat C
Rev Neurol (Paris); 1973 Jan; 128(1):72-7. PubMed ID: 4367744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
